// App-Quantinova.ai

231P : FETOPROTEIN (AFP) RESPONSE BY GC33 CORRELATES TO PROGRESSION FREE SURVIVAL (PFS) IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC)

Researchers

Presenter

  • Y. Jin

Principal Investigators

  • J. Shi

  • A. Phipps

  • M. Nakamura

  • T. Ohtomo

  • R. Lee

  • Y. Chen

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • F. Hoffmann-La Roche

  • Chugai Pharmaceutica

  • Feng Chi Biotech Cor

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

Biomarkers

  • Alpha-fetoprotein

Drug/Treatment

  • GC33

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved